The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting.

The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting.

Anti-neutrophil cytoplasmic antibody (ANCA) tests are a routine clinical assay in most UK hospitals. We examined the role of routine ANCA testing in achieving a diagnosis of systemic vasculitis in a routine clinical setting. From April 1996 to March 2000, 2734 samples from five hospital departments...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	McLaren, J, Stimson, R, McRorie, E, Coia, J, Luqmani, R
Format:	Journal article
Sprache:	English
Veröffentlicht:	2001

Ähnliche Einträge

Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
von: McLaren, J, et al.
Veröffentlicht: (2001)

A four year analysis of variation in use of the anti-neutrophil cytoplasmic antibody (ANCA) test as a screening tool for ANCA-associated systemic vasculitis (AAV) in a teaching hospital.
von: McLaren, J, et al.
Veröffentlicht: (2000)

Diagnosis and assessment of systemic vasculitis.
von: McLaren, J, et al.
Veröffentlicht: (2002)

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.
von: Basu, N, et al.
Veröffentlicht: (2014)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
von: Robson, J, et al.
Veröffentlicht: (2017)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
von: Guerry, M, et al.
Veröffentlicht: (2012)

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis
von: Pearce, F, et al.
Veröffentlicht: (2017)

A disease-specific patient-reported outcome for anti-neutrophil cytoplasmic antibody–associated vasculitis: scale structure and measurement properties of the anti-neutrophil cytoplasmic antibody-associated vasculitis patient-reported outcome measure
von: Robson, J, et al.
Veröffentlicht: (2017)

Anti-neutrophil Cytoplasmic Antibodies and Glomerulonephritis: An Update
von: Oda Takashi
Veröffentlicht: (2000-01-01)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
von: Thomas Hellmark, et al.
Veröffentlicht: (2019-03-01)

Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.
von: Latimer, N, et al.
Veröffentlicht: (2014)

Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal
von: Latimer, N, et al.
Veröffentlicht: (2014)

DEVELOPMENT OF DIAGNOSTIC CRITERIA FOR PRIMARY ANCA-ASSOCIATED SYSTEMIC VASCULITIS (AASV)
von: McLaren, J, et al.
Veröffentlicht: (2003)

Advances in the Assessment and Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis
von: Ni A, et al.
Veröffentlicht: (2024-12-01)

DIAGNOSTIC CRITERIA FOR ANCA-ASSOCIATED PRIMARY SYSTEMIC VASCULITIS (AASV) IN PATIENTS PRESENTING WITH ACUTE PULMONARY AND/OR RENAL DISEASE
von: McLaren, J, et al.
Veröffentlicht: (2004)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
von: Valentina Binda, et al.
Veröffentlicht: (2021-12-01)

Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
von: Alan D. Salama
Veröffentlicht: (2020-01-01)

Predictors of renal outcomes in anti-neutrophil cytoplasmic antibody glomerulonephritis
von: Hela Jebali, et al.
Veröffentlicht: (2020-01-01)

Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
von: Cheng-Hua Weng, et al.
Veröffentlicht: (2019-12-01)

Scale Structure and Measurement Properties of a Disease Specific Patient-Reported Outcome for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
von: Robson, J, et al.
Veröffentlicht: (2016)

Cytoplasmic-anti-neutrophil cytoplasmic antibodies targeting myeloperoxidase in Wegener′s granulomatosis: A rare phenomenon
von: Bhavana M Venkatesh, et al.
Veröffentlicht: (2014-01-01)

Rheumatoid constrictive pericarditis
von: McRorie, E, et al.
Veröffentlicht: (1997)

Rheumatoid constrictive pericarditis.
von: McRorie, E, et al.
Veröffentlicht: (1997)

Rheumatoid constrictive pericarditis.
von: McRorie, E, et al.
Veröffentlicht: (1997)

ANTI NEUTROPHIL CYTOPLASMIC AUTOANTIBODIES IN UVEITIS
von: M. Vndjgani, et al.
Veröffentlicht: (2000-04-01)

Cardiovascular and Cerebrovascular Outcomes in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis
von: Shiyu Xiao, et al.
Veröffentlicht: (2024-01-01)

Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
von: Christopher Maximilian Arends, et al.
Veröffentlicht: (2020-06-01)

Role of complement activation in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
von: Tadasu Kojima, et al.
Veröffentlicht: (2022-12-01)

Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus
von: Fang Su, et al.
Veröffentlicht: (2017-08-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
von: Haiting Wu, et al.
Veröffentlicht: (2022-04-01)

A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis
von: Marta Casal Moura, et al.
Veröffentlicht: (2022-11-01)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
von: Daisuke Tsukui, et al.
Veröffentlicht: (2021-01-01)

Clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in French children
von: Salomon R, et al.
Veröffentlicht: (2011-09-01)

Clinical significance of HEp-2 cell cytoplasmic patterns in anti-neutrophil cytoplasmic antibody associated vasculitis
von: Naidan Zhang, MS, et al.
Veröffentlicht: (2022-06-01)

Lupus-like nephritis with positive anti-neutrophil cytoplasmic antibodies and negative antinuclear antibodies
von: Joana Eugénio Santos, et al.
Veröffentlicht: (2020-10-01)

Cardiovascular Outcomes Are Worse In Microscopic Polyangiitis Compared To Granulomatosis With Polyangiitis: Data From An Inception Cohort Of Patients With Anti-Neutrophil Cytoplasm Antibody Associated Systemic Vasculitis
von: Mistry, A, et al.
Veröffentlicht: (2013)

Oral Microbiota Profile in Patients with Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
von: Anders Esberg, et al.
Veröffentlicht: (2022-08-01)

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.
von: Robson, J, et al.
Veröffentlicht: (2014)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
von: Hellmich, B, et al.
Veröffentlicht: (2007)

Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report
von: Haruki Shida, et al.
Veröffentlicht: (2018-06-01)